Resources by Therapeutic Area
Contributed by: Denise Myshko
Learn about the next-generation Simoa biomarker detection technology that enables researchers to multiplex up to 10 analytes with unprecedented sensitivity.
In an excerpt from a panel discussion which took place at MedCity CONVERGE on July 11, 2018, Quanterix Chairman and CEO Kevin Hrusovsky joins other key innovators to discuss game-changing biotech advancements and the future of healthcare.
We're passionate about the work we do and believe we can transform today’s sick care into tomorrow’s precision healthcare.